Last $4.10 USD
Change Today -- / 1.23%
Volume 2.4M
DNDN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 06/17/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mitchell H. Gold M.D.

Former Executive Director, Dendreon Corp.
AgeTotal Calculated CompensationThis person is connected to 156 board members in 2 different organizations across 3 different industries.

See Board Relationships
44$6,707,623
As of Fiscal Year 2012

Background*

Dr. Mitchell H. Gold, Mitch, M.D. is a Founder of Alpine Biosciences and serves as its chairman and Chief Executive Officer. Dr. Gold served as the Chief Executive Officer and President of Dendreon Corp. from January 1, 2003 to February 1, 2012. Dr. Gold served as Vice President of Business Development at Dendreon June 2001 to May 2002 and also served as its Chief Business Officer from May 2002 to December 2002. From April 2000 to May 2001, Dr. Gold served as Vice President ...

Read Full Background

Corporate Headquarters*

1301 2nd Avenue
Seattle, Washington 98101

United States

Phone: 206-256-4545
Fax: 206-256-0571

Board Members Memberships*

Director
2002-2013
Former Executive Director
2012-Present
Member of The Board of Directors

Education*

BS 1989
University of Wisconsin - Madison
MD 1993
Rush Medical College, Chicago

Other Affiliations*

Annual Compensation*

Salary$483,073
Total Annual Compensation$483,073

Stock Options*

Restricted Stock Awards$3,477,600
All Other Compensation$2,360,200

Total Compensation*

Total Annual Cash Compensation$3,085,273
Total Short Term Compensation$483,073
Other Long Term Compensation$5,837,800
Total Calculated Compensation$6,707,623
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DNDN:US $4.10 USD --

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$864.8K
Christopher Nishan Garabedian Chief Executive Officer, President and Director
Sarepta Therapeutics, Inc.
$490.0K
Rajesh C. Shrotriya M.D.Chairman, Chief Executive Officer, President, Chairman of Placement Committee and Chairman of Product Acquisition Committee
Spectrum Pharmaceuticals, Inc.
$2.4M
Mark R. Baker J.D.Chief Executive Officer, Director, Member of Science & Technology Committee and Member of Strategy & External Technology Subcommittee
Progenics Pharmaceuticals, Inc.
$672.8K
Joseph S. Zakrzewski Executive Chairman and Chief Executive Officer
Amarin Corporation plc
$550.0K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DENDREON CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.